Reza Skandari joined Imperial College Business School in 2018. He is an Assistant Professor of Health Operations in the Operations Management group and affiliated with the Centre for Health Economics & Policy Innovation. Prior to that he worked as a Senior Research Analyst at the Center for Translational and Policy Research of Chronic Diseases at the University of Chicago School of Medicine. He obtained his PhD in Management Science from the Sauder School of Business, University of British Columbia.
Reza's main research interests are in: (1) Health-care Operations Management and Analytics (2) Health-care Policy Research and Economics (3) Clinical Decision Making (4) Dynamic Programming and Stochastic Optimization.
et al., 2022, Development and validation of a decision analytical model for posttreatment surveillance for patients with oropharyngeal carcinoma, Jama Network Open, Vol:5, ISSN:2574-3805
et al., 2021, Longer-term benefits and risks of sodium-glucose cotransporter-2 inhibitors in Type 2 diabetes: a systematic review and meta-analysis, Journal of General Internal Medicine, Vol:37, ISSN:0884-8734, Pages:439-448
et al., 2021, The longer-term benefits and harms of glucagon-like peptide-1 receptor agonists: a systematic review and meta-analysis, Journal of General Internal Medicine, Vol:37, ISSN:0884-8734, Pages:415-438
Skandari MR, Shechter SM, 2021, Patient-Type Bayes-Adaptive Treatment Plans, Operations Research, Vol:69, ISSN:0030-364X, Pages:574-598
et al., 2020, Alternative type 2 diabetes screening tests may reduce the number of US adults with undiagnosed diabetes, Diabetic Medicine, Vol:37, ISSN:0742-3071, Pages:1935-1943